Pertussis: An update on primary prevention and outbreak control

American Family Physician

Volumn 56, Issue 4, 1997, Pages 1121-1128

  Scott, Paul T ^a   Clark, Jeffrey B ^a   Miser, William F ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; PERTUSSIS VACCINE;

ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CLINICAL FEATURE; EPIDEMIC; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INCIDENCE; PERTUSSIS; PRIMARY PREVENTION; SEROLOGY; VACCINATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INCIDENCE; UNITED STATES; WHOOPING COUGH;

EID: 0030758908     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Atkinson W, Furphy L, Gant J, Mayfield M. Pertussis. In: Epidemiology and prevention of vaccine-preventable diseases. Atkinson W, et al., eds. 2d ed. Atlanta, Ga.: Centers for Disease Control and Prevention, Department of Health and Human Services, 1995:57-72.
2. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States 1994. MMWR Morb Mortal Wkly Rep 1994;43:1-80.
3. Centers for Disease Control and Prevention. Pertussis - United States, January 1992-June 1995. MMWR Morb Mortal Wkly Rep 1995;44:525-9.
4. Muller AS, Leeuwenburg J, Pratt DS. Pertussis: epidemiology and control. Bull World Health Organ 1986:64:321-31.
5. Feigin RD, Cherry JD, eds. Pertussis. In: Textbook of pediatric infectious diseases. 3d ed. Philadelphia: Saunders, 1992:1208-18.
6. Sprauer MA, Cochi SL, Zell ER, Sutler RW, Mullen JR, Englender SJ, et al. Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child 1992;146:177-81.
7. Bortolussi R, Miller B, Ledwith M, Halperin S. Clinical course of pertussis in immunized children. Pediatr Infect Dis J 1995;14:870-4.
8. Bass JW. Pertussis: current status of prevention and treatment. Pediatr Infect Dis 1985;4:614-9.
9. Farizo KM, Cochi SL, Zell ER, Brink EW, Wassilak SG, Patriarca PA. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992;14:708-19.
10. Postels-Multani S, Schmitt HJ, Wirsing von Konig CH, Bock HL, Bogaerts H. Symptoms and complications of pertussis in adults. Infection 1995;23:139-42.
11. Feigin RG. Pertussis (whooping cough). In: Berman RE, Kliegman RM, Nelson WE, Vaughan VC III, eds. Nelson textbook of pediatrics. 14th ed. Philadelphia: Saunders, 1992:724-5.
12. Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, et al. Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health 1988;78:833-6.
13. Onorato IM, Wassilak SG. Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J 1987;6:145-51.
14. Halperin SA, Bortolussi R, Wort AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol 1989;27:752-7.
15. Bergquist SO, Bernander S, Dahnsjo H, Sundelof B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987;6:458-61 [Published erratum appears in Pediatr Infect Dis J 1987;6:1035].
16. Statement on management of persons exposed to pertussis and pertussis outbreak control. Can Commun Dis Rep 1994;20:193-200.
17. Alexander ER, Debolt C. Pertussis alert. Seattle-King County Department of Public Health; July 1996:1-5.
18. Badr-El-Din MK, Aref GH, Kassem AS, Abdel-Moneim MA, Abbassy AA. A beta-adrenergic stimulant, salbutamol, in the treatment of pertussis. J Trop Med Hyg 1976;79:218-9.
19. Pavesio D, Ponzone A. Salbutamol and pertussis [Letter]. Lancet 1977;1(8003):150-1.
20. Peltola H, Michelsson K. Efficacy of salbutamol in treatment of infant pertussis demonstrated by sound spectrum analysis. Lancet 1982;1(8267):310-2.
21. Chandra H, Rao CS, Karan S, Mathur YC. Evaluation of betamethasone and isoniazid along with chloramphenicol in the management of whooping cough. Indian Pediatr 1972;9:70-3.
22. Zoumboulakis D, Anagnostakis K, Albanis V, et al. Steroids in treatment of pertussis. A controlled clinical trial. Arch Dis Child 1973;48:51-4.
23. American Academy of Pediatrics. Pertussis. In: 1994 Red book: report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village, Ill.: American Academy of Pediatrics, 1994:356.
24. De Serres G, Boulianne N, Duval B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr Infect Dis J 1995; 14:969-75.
25. Steketee RW, Wassilak SG, Adkins WN Jr, Burstyn DG, Manclark CR, Berg J, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988;157:434-40.
26. Centers for Disease Control and Prevention. Update: Vaccine side effects, adverse reactions, contra-indications, and precautions-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996; 45(RR-12):22-31.
27. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40:1-28.
28. Onorato IM, Wassilak SG, Meade B. Efficacy of whole-cell pertussis vaccine in preschool children in the United States. JAMA 1992;267:2745-9.
29. Cherry JD. Nosocomial pertussis in the nineties [Editorial]. Infect Control Hosp Epidemiol 1995; 16:553-5.
30. Shefer A, Dales L, Nelson M, Werner B, Baron R, Jackson R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995;171:1053-6.
31. Poland GA. Acellular pertussis vaccines: new vaccines for an old disease. Lancet 1996;347:209-10.